Serum cytokine and chemokine profiles in patients with myasthenia gravis

av Uzawa, A, Kawaguchi, N, Himuro, K, Kanai, T, Kuwabara, S
Publicerad 2014

Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study

av Uzawa, A., Kojima, Y., Ozawa, Y., Yasuda, M., Onishi, Y., Akamine, H., Kawaguchi, N., Himuro, K., Kuwabara, S.
I publikationen Clin Exp Immunol (2020)